Fewer vaccine doses still support pneumococcal immunity, shows clinical trial
A unique study published this month outlines new ways to protect more of the world's population from vaccine-preventable diseases.
Apr 26, 2023
0
29
A unique study published this month outlines new ways to protect more of the world's population from vaccine-preventable diseases.
Apr 26, 2023
0
29
A mysterious illness causing fevers and headaches and leading to rapid development of acute encephalitis (within a couple of weeks of symptom onset), caused an outbreak of nearly 300 reported cases and over 100 fatalities ...
Apr 20, 2023
0
7
Pregnant women were hesitant to get the COVID-19 vaccine as a result of mixed public messaging and concerns over safety, according to the results of a study which analyzed social media posts.
Apr 20, 2023
0
2
A new HIV vaccine from Scripps Research has shown a significantly improved ability to neutralize the virus in preclinical tests, and it will soon be studied in healthy people who volunteer to participate in clinical trials.
Apr 20, 2023
0
46
With the FDA authorizing a second bivalent booster this week for individuals at high risk from COVID-19 and the CDC expected to sign off on it as well, a recent Houston Methodist study may offer some guidance on when certain ...
Apr 19, 2023
0
6
A low-cost, protein-based COVID-19 vaccine tested in rhesus monkeys by Stanford Medicine researchers and colleagues offered immunity against known variants for at least one year. Researchers hope the vaccine, which can remain ...
Apr 18, 2023
0
33
A study led by University at Buffalo researchers has confirmed that contrary to claims by anti-vaccine proponents, COVID-19 vaccines pose only trivial risk of venous thromboembolism (VTE), or blood clots. In addition, the ...
Apr 14, 2023
0
20
Warning: this article may contain spoilers.
Mar 17, 2023
0
5
An experimental COVID-19 vaccine produced with technology based on a decades-old method, elicited virus-neutralizing antibodies in higher proportion than the amount induced by mRNA immunizations, a Phase 1 clinical trial ...
Anna Durbin was in Brazil in December 2015 when the Zika virus erupted in the country's northeast. Although she'd flown to São Paulo to work on a dengue vaccine, Durbin returned to Baltimore preoccupied with Zika.
Mar 15, 2023
0
12